UHAL-B(UHAL-B)
UHAL-B
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for UHAL-B
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $6.30B | $6.64B |
| Low | $6.22B | $6.46B |
| High | $6.37B | $6.82B |
| EBITDA Avg | $2.17B | $2.28B |
| Low | $2.14B | $2.22B |
| High | $2.19B | $2.34B |
| EBIT Avg | $1.18B | $1.24B |
| Low | $1.16B | $1.21B |
| High | $1.19B | $1.28B |
| Net Income Avg | $220M | $424M |
| Low | $214M | $412M |
| High | $225M | $434M |
| EPS Avg | $1.12 | $2.16 |
| Low | $1.09 | $2.10 |
| High | $1.15 | $2.21 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $1.79B | $1.49B |
| Low | $1.76B | $1.47B |
| High | $1.81B | $1.51B |
| EBITDA Avg | $615M | $513M |
| Low | $606M | $506M |
| High | $623M | $519M |
| EBIT Avg | $335M | $279M |
| Low | $330M | $276M |
| High | $340M | $283M |
| Net Income Avg | $102M | $35M |
| Low | $100M | $35M |
| High | $103M | $36M |
| EPS Avg | $0.52 | $0.18 |
| Low | $0.51 | $0.18 |
| High | $0.53 | $0.18 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 |